RBC Capital Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)
Express News | Biohaven Ltd : RBC Cuts Target Price to $59 From $61
Express News | Biohaven Ltd Q1 Shr View $-1.57 -- Lseg Ibes Data
Express News | Biohaven Ltd: Qtrly Adj Net Loss $1.77 per Share
Press Release: Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments PR Newswire NEW HAVEN, Conn., May 9, 2024 -- Cash, cash equivalents, marketable securities and restricted c
Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Express News | Biohaven Ltd : UBS Raises Target Price to $60 From $59
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Becton Dickinson (BDX)
Express News | Biohaven Ltd: Offering 5.6 Mln of Common Shares in This Offering at Price per Common Share of $41.00
Express News | Biohaven Ltd - Pricing of Its Underwritten Public Offering of 5,609,757 of Its Common Shares at a Price to Public of $41.00 per Share
Express News | Biohaven Ltd - Files for Offering of Its Common Shares of up to $200 Mln
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
Buy Rating Affirmed: Biohaven Ltd. Poised for Key Milestones With Diverse Portfolio and Promising Lead Molecule BHV-7000
Buy Rating Affirmed for Biohaven Ltd. on Strong Pipeline and Upcoming Drug Advancements
Piper Sandler Remains a Buy on Biohaven Ltd. (BHVN)
Analysts Offer Insights on Healthcare Companies: Seer (SEER) and Biohaven Ltd. (BHVN)
Calculating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Biohaven fair value estimate is US$46.01 Biohaven's US$49.50 share price indicates it is trading at similar levels as its fair value estimate
No Data